GLOBAL BLOOD FUND – Trademark Portfolio

Entity Type: 99

GLOBAL BLOOD FUND holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GLOBAL BLOOD FUND and GBF GLOBAL BLOOD FUND. The owner is based in Oklahoma City, OK.

1001 N. Lincoln Blvd.

Oklahoma City, OK 73104

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GLOBAL BLOOD FUND's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does GLOBAL BLOOD FUND have?

GLOBAL BLOOD FUND has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does GLOBAL BLOOD FUND file in?

GLOBAL BLOOD FUND files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What are GLOBAL BLOOD FUND's most well-known trademarks?

GLOBAL BLOOD FUND's registered trademark portfolio includes well-known marks such as GLOBAL BLOOD FUND and GBF GLOBAL BLOOD FUND. These are among 2 currently registered trademarks in the portfolio.

What is GLOBAL BLOOD FUND's trademark registration success rate?

GLOBAL BLOOD FUND has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.